National performance by cancer pathway

Summary

This page shows the percentages of patients within waiting times standards, by cancer type, treatment modality, and referral or treatment pathway. Performance varies substantially across all aspects of these pathways.

Time period of data: October 2023 to February 2025

28-day Faster Diagnosis Standard

Figure 1: 28-day Faster Diagnosis Standard - Percentage of patients within the standard plotted against the percentage of all breaches, by cancer type and referral group

31-day treatment standard

Cancer type by first or subsequent treatment

Figure 2: 31-day treatment standard - Percentage of patients within the standard plotted against the percentage of all breaches, by cancer type and first or subsequent treatment

Treatment modality by first or subsequent treatment

Figure 3: 31-day treatment standard - Percentage of patients within the standard plotted against the percentage of all breaches, by treatment modality and first or subsequent treatment

62-day treatment standard

Cancer type by referral group

Figure 4: 62-day treatment standard - Percentage of patients within the standard plotted against the percentage of all breaches, by cancer type and referral group

Treatment modality by referral group

Figure 5: 62-day treatment standard - Percentage of patients within the standard plotted against the percentage of all breaches, by treatment modality and referral group